STUDY OBJECTIVE: People with narcolepsy and mice lacking orexin/hypocretin have disrupted sleep/wake behavior and reduced physical activity. Our objective was to identify physiologic mechanisms through which orexin deficiency reduces locomotor activity. DESIGN: We examined spontaneous wheel running activity and its relationship to sleep/wake behavior in wild type (WT) and orexin knockout (KO) mice. Additionally, given that physical activity promotes alertness, we also studied whether orexin deficiency reduces the wake-promoting effects of exercise. MEASUREMENTS AND RESULTS: Orexin KO mice ran 42% less than WT mice. Their ability to run appeared normal as they initiated running as often as WT mice and ran at normal speeds. However, their running bouts were considerably shorter, and they often had cataplexy or quick transitions into sleep after running. Wheel running increased the total amount of wakefulness in WT and orexin KO mice similarly, however, KO mice continued to have moderately fragmented sleep/wake behavior. Wheel running also doubled the amount of cataplexy by increasing the probability of transitioning into cataplexy. CONCLUSIONS: Orexin KO mice run significantly less than normal, likely due to sleepiness, imminent cataplexy, or a reduced motivation to run. Orexin is not required for the wake-promoting effects of wheel running given that both WT and KO mice had similar increases in wakefulness with running wheels. In addition, the clear increase in cataplexy with wheel running suggests the possibility that positive emotions or reward can trigger murine cataplexy, similar to that seen in people and dogs with narcolepsy.
STUDY OBJECTIVE:People with narcolepsy and mice lacking orexin/hypocretin have disrupted sleep/wake behavior and reduced physical activity. Our objective was to identify physiologic mechanisms through which orexindeficiency reduces locomotor activity. DESIGN: We examined spontaneous wheel running activity and its relationship to sleep/wake behavior in wild type (WT) and orexin knockout (KO) mice. Additionally, given that physical activity promotes alertness, we also studied whether orexin deficiency reduces the wake-promoting effects of exercise. MEASUREMENTS AND RESULTS:Orexin KO mice ran 42% less than WT mice. Their ability to run appeared normal as they initiated running as often as WT mice and ran at normal speeds. However, their running bouts were considerably shorter, and they often had cataplexy or quick transitions into sleep after running. Wheel running increased the total amount of wakefulness in WT and orexin KO mice similarly, however, KO mice continued to have moderately fragmented sleep/wake behavior. Wheel running also doubled the amount of cataplexy by increasing the probability of transitioning into cataplexy. CONCLUSIONS:Orexin KO mice run significantly less than normal, likely due to sleepiness, imminent cataplexy, or a reduced motivation to run. Orexin is not required for the wake-promoting effects of wheel running given that both WT and KO mice had similar increases in wakefulness with running wheels. In addition, the clear increase in cataplexy with wheel running suggests the possibility that positive emotions or reward can trigger murine cataplexy, similar to that seen in people and dogs with narcolepsy.
Authors: Y Yoshida; N Fujiki; T Nakajima; B Ripley; H Matsumura; H Yoneda; E Mignot; S Nishino Journal: Eur J Neurosci Date: 2001-10 Impact factor: 3.386
Authors: I V Estabrooke; M T McCarthy; E Ko; T C Chou; R M Chemelli; M Yanagisawa; C B Saper; T E Scammell Journal: J Neurosci Date: 2001-03-01 Impact factor: 6.167
Authors: Martin Werme; Chad Messer; Lars Olson; Lauren Gilden; Peter Thorén; Eric J Nestler; Stefan Brené Journal: J Neurosci Date: 2002-09-15 Impact factor: 6.167
Authors: Tatiana M Korotkova; Olga A Sergeeva; Krister S Eriksson; Helmut L Haas; Ritchie E Brown Journal: J Neurosci Date: 2003-01-01 Impact factor: 6.167
Authors: Jon T Willie; Richard M Chemelli; Christopher M Sinton; Shigeru Tokita; S Clay Williams; Yaz Y Kisanuki; Jacob N Marcus; Charlotte Lee; Joel K Elmquist; Kristi A Kohlmeier; Christopher S Leonard; James A Richardson; Robert E Hammer; Masashi Yanagisawa Journal: Neuron Date: 2003-06-05 Impact factor: 17.173
Authors: T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel Journal: Neuron Date: 2000-09 Impact factor: 17.173
Authors: Carrie E Mahoney; Lindsay J Agostinelli; Jessica N K Brooks; Bradford B Lowell; Thomas E Scammell Journal: J Neurosci Date: 2017-02-24 Impact factor: 6.167
Authors: Sarah Wurts Black; Stephen R Morairty; Tsui-Ming Chen; Andrew K Leung; Jonathan P Wisor; Akihiro Yamanaka; Thomas S Kilduff Journal: J Neurosci Date: 2014-05-07 Impact factor: 6.167
Authors: Sarah Wurts Black; Stephen R Morairty; Simon P Fisher; Tsui-Ming Chen; Deepti R Warrier; Thomas S Kilduff Journal: Sleep Date: 2013-03-01 Impact factor: 5.849